A citation-based method for searching scientific literature

Jun Takei, Toshihide Tanaka, Akihiko Teshigawara, Satoru Tochigi, Yuzuru Hasegawa, Yuichi Murayama. Transl Cancer Res 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.
Yuji Piao, Ji Liang, Lindsay Holmes, Amado J Zurita, Verlene Henry, John V Heymach, John F de Groot. Neuro Oncol 2012
164
100

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Shideng Bao, Qiulian Wu, Roger E McLendon, Yueling Hao, Qing Shi, Anita B Hjelmeland, Mark W Dewhirst, Darell D Bigner, Jeremy N Rich. Nature 2006
100

Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy.
Michael DeLay, Arman Jahangiri, W Shawn Carbonell, Yu-Long Hu, Sean Tsao, Maxwell Wing Tom, Jesse Paquette, Taku A Tokuyasu, Manish K Aghi. Clin Cancer Res 2012
82
100

Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.
Emmanuelle di Tomaso, Matija Snuderl, Walid S Kamoun, Dan G Duda, Pavan K Auluck, Ladan Fazlollahi, Ovidiu C Andronesi, Matthew P Frosch, Patrick Y Wen, Scott R Plotkin,[...]. Cancer Res 2011
142
100

Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma.
Martha Nowosielski, Benedikt Wiestler, Georg Goebel, Markus Hutterer, Heinz P Schlemmer, Günther Stockhammer, Wolfgang Wick, Martin Bendszus, Alexander Radbruch. Neurology 2014
76
100

Histopathological investigation of glioblastomas resected under bevacizumab treatment.
Ryota Tamura, Toshihide Tanaka, Keisuke Miyake, Yusuke Tabei, Kentaro Ohara, Oltea Sampetrean, Maya Kono, Katsuhiro Mizutani, Yohei Yamamoto, Yuichi Murayama,[...]. Oncotarget 2016
32
100

Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
N J Beasley, C C Wykoff, P H Watson, R Leek, H Turley, K Gatter, J Pastorek, G J Cox, P Ratcliffe, A L Harris. Cancer Res 2001
200
100

Cancer Stem Cell Hierarchy in Glioblastoma Multiforme.
Amy Bradshaw, Agadha Wickremsekera, Swee T Tan, Lifeng Peng, Paul F Davis, Tinte Itinteang. Front Surg 2016
158
100

Cell surface Nestin is a biomarker for glioma stem cells.
Xiong Jin, Xun Jin, Ji-Eun Jung, Samuel Beck, Hyunggee Kim. Biochem Biophys Res Commun 2013
74
100

Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.
Dagmar Beier, Joerg B Schulz, Christoph P Beier. Mol Cancer 2011
215
100

What is the clinical value of cancer stem cell markers in gliomas?
Rikke Hedegaard Dahlrot, Simon Kjær Hermansen, Steinbjørn Hansen, Bjarne Winther Kristensen. Int J Clin Exp Pathol 2013
63
100


Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?
Stefan Kaluz, Milota Kaluzová, Shu-Yuan Liao, Michael Lerman, Eric J Stanbridge. Biochim Biophys Acta 2009
174
100

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.
N Weidner, J P Semple, W R Welch, J Folkman. N Engl J Med 1991
100

Tumor vascularity: a histological measure of angiogenesis and hypoxia.
C M West, R A Cooper, J A Loncaster, D P Wilks, M Bromley. Cancer Res 2001
74
100

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death.
Anna-Luisa Luger, Nadja I Lorenz, Hans Urban, Iris Divé, Anna L Engel, Florian Strassheimer, Katja Dettmer, Pia S Zeiner, Shabnam Shaid, Nina Struve,[...]. Cancers (Basel) 2020
4
100

Fiji: an open-source platform for biological-image analysis.
Johannes Schindelin, Ignacio Arganda-Carreras, Erwin Frise, Verena Kaynig, Mark Longair, Tobias Pietzsch, Stephan Preibisch, Curtis Rueden, Stephan Saalfeld, Benjamin Schmid,[...]. Nat Methods 2012
100


Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.
Benjamin M Ellingson, Lauren E Abrey, Josep Garcia, Olivier Chinot, Wolfgang Wick, Frank Saran, Ryo Nishikawa, Roger Henriksson, Warren P Mason, Robert J Harris,[...]. Neuro Oncol 2018
12
100

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
A Soeda, M Park, D Lee, A Mintz, A Androutsellis-Theotokis, R D McKay, J Engh, T Iwama, T Kunisada, A B Kassam,[...]. Oncogene 2009
468
100

Molecular markers in glioma.
Kirsten Ludwig, Harley I Kornblum. J Neurooncol 2017
166
100

Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
Shunsuke Shibao, Noriaki Minami, Naoyoshi Koike, Nobuyuki Fukui, Kazunari Yoshida, Hideyuki Saya, Oltea Sampetrean. Neuro Oncol 2018
36
100

Modes of resistance to anti-angiogenic therapy.
Gabriele Bergers, Douglas Hanahan. Nat Rev Cancer 2008
100

Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab.
Ryota Tamura, Toshihide Tanaka, Kentaro Ohara, Keisuke Miyake, Yukina Morimoto, Yohei Yamamoto, Ryuichi Kanai, Yasuharu Akasaki, Yuichi Murayama, Takashi Tamiya,[...]. Cancer Sci 2019
37
100

FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.
Nu Zhang, Xinjian Wu, Lixuan Yang, Feizhe Xiao, Heng Zhang, Aidong Zhou, Zhengsong Huang, Suyun Huang. Clin Cancer Res 2012
73
100

FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells.
Yujian Zhang, Nu Zhang, Bingbing Dai, Mingguang Liu, Raymond Sawaya, Keping Xie, Suyun Huang. Cancer Res 2008
154
100

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Patrick Y Wen, David R Macdonald, David A Reardon, Timothy F Cloughesy, A Gregory Sorensen, Evanthia Galanis, John Degroot, Wolfgang Wick, Mark R Gilbert, Andrew B Lassman,[...]. J Clin Oncol 2010
100

"Paradoxical" findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab.
Yohei Yamamoto, Ryota Tamura, Toshihide Tanaka, Kentaro Ohara, Yukina Tokuda, Keisuke Miyake, Jun Takei, Yasuharu Akasaki, Kazunari Yoshida, Yuichi Murayama,[...]. Oncotarget 2017
11
100

Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.
Felix Behling, Alonso Barrantes-Freer, Carl Ludwig Behnes, Florian Stockhammer, Veit Rohde, Antonia Adel-Horowski, Odir Antonio Rodríguez-Villagra, Miguel Angel Barboza, Wolfgang Brück, Ulrich Lehmann,[...]. PLoS One 2020
3
100

A perivascular niche for brain tumor stem cells.
Christopher Calabrese, Helen Poppleton, Mehmet Kocak, Twala L Hogg, Christine Fuller, Blair Hamner, Eun Young Oh, M Waleed Gaber, David Finklestein, Meredith Allen,[...]. Cancer Cell 2007
100

Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio.
Martha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, Josep Garcia, Cedric Revil, Alexander Radbruch, Ryo Nishikawa, Warren P Mason, Roger Henriksson, Frank Saran,[...]. Neuro Oncol 2018
16
100

Chemotherapy resistance of glioblastoma stem cells.
A Eramo, L Ricci-Vitiani, A Zeuner, R Pallini, F Lotti, G Sette, E Pilozzi, L M Larocca, C Peschle, R De Maria. Cell Death Differ 2006
464
100

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.
Fred Fack, Heidi Espedal, Olivier Keunen, Anna Golebiewska, Nina Obad, Patrick N Harter, Michel Mittelbronn, Oliver Bähr, Astrid Weyerbrock, Linda Stuhr,[...]. Acta Neuropathol 2015
84
100

FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.
Mingguang Liu, Bingbing Dai, Shin-Hyuk Kang, Kechen Ban, Feng-Ju Huang, Frederick F Lang, Kenneth D Aldape, Tong-xin Xie, Christopher E Pelloski, Keping Xie,[...]. Cancer Res 2006
258
100

CNS stem cells express a new class of intermediate filament protein.
U Lendahl, L B Zimmerman, R D McKay. Cell 1990
100

Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma.
Kosuke Takigawa, Nobuhiro Hata, Yuhei Michiwaki, Akio Hiwatashi, Hajime Yonezawa, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Yusuke Funakoshi,[...]. J Neurooncol 2021
3
100

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
Mingyu Zhang, Tao Song, Liang Yang, Ruokun Chen, Lei Wu, Zhuanyi Yang, Jiasheng Fang. J Exp Clin Cancer Res 2008
192
100

Alternative Vascularization Mechanisms in Tumor Resistance to Therapy.
Dorina Belotti, Denise Pinessi, Giulia Taraboletti. Cancers (Basel) 2021
8
100

Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors.
R A Cairns, T Kalliomaki, R P Hill. Cancer Res 2001
227
100

Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.
Christine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, Jermaine Goveia, Christian Davidson, Yuhui Huang, Lars Riedemann, Jennie Taylor, Percy Ivy, Dan G Duda,[...]. Neuro Oncol 2013
146
100

Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas.
Sean Mahase, Rachel N Rattenni, Pieter Wesseling, William Leenders, Clarissa Baldotto, Rajan Jain, David Zagzag. Am J Pathol 2017
45
100

Vascular normalization as an emerging strategy to enhance cancer immunotherapy.
Yuhui Huang, Shom Goel, Dan G Duda, Dai Fukumura, Rakesh K Jain. Cancer Res 2013
377
100

PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.
Dolores Hambardzumyan, Oren J Becher, Marc K Rosenblum, Pier Paolo Pandolfi, Katia Manova-Todorova, Eric C Holland. Genes Dev 2008
354
100

Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
Shigeru Yamaguchi, Kenji Hirata, Takuya Toyonaga, Kentaro Kobayashi, Yukitomo Ishi, Hiroaki Motegi, Hiroyuki Kobayashi, Tohru Shiga, Nagara Tamaki, Shunsuke Terasaka,[...]. PLoS One 2016
18
100

Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
Nobuyuki Kawai, Wei Lin, Wei-Dong Cao, Daisuke Ogawa, Keisuke Miyake, Reiji Haba, Yukito Maeda, Yuka Yamamoto, Yoshihiro Nishiyama, Takashi Tamiya. Eur J Nucl Med Mol Imaging 2014
48
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.